Detalhe da pesquisa
1.
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study.
Lancet HIV
; 9(8): e534-e543, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35905752